Giulio Nannetti

发表

Antiviral strategies against influenza virus: towards new therapeutic approaches

G. Palù, A. Loregian, C. Compagnin, 2014, Cellular and Molecular Life Sciences.

Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase

M. Loza, J. Brea, L. Goracci, 2020, European Journal of Medicinal Chemistry.

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of Influenza Virus PA-PB 1 interaction

Arianna, F. Musumeci, A. L. Fallacara, 2018 .

Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives.

L. Goracci, A. Loregian, Giulio Nannetti, 2017, Organic & biomolecular chemistry.

Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds.

L. Goracci, G. Cruciani, G. Palù, 2014, Journal of medicinal chemistry.

Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity.

L. Goracci, G. Palù, A. Loregian, 2017, European journal of medicinal chemistry.

A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.

L. Goracci, G. Cruciani, G. Palù, 2015, Journal of medicinal chemistry.

A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells

G. Palù, A. Loregian, B. Mercorelli, 2018, Scientific Reports.

Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase

A. Brancale, R. Silvestri, J. Neyts, 2022, Viruses.

4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling.

I. D. de Esch, C. Tintori, A. L. Fallacara, 2016, Journal of medicinal chemistry.

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.

F. Musumeci, A. L. Fallacara, S. Schenone, 2018, European journal of medicinal chemistry.

A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma.

G. Palù, A. Loregian, Giulio Nannetti, 2018, Biomedical chromatography : BMC.

Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly.

L. Goracci, G. Cruciani, G. Palù, 2013, Journal of medicinal chemistry.

Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma

G. Palù, A. Loregian, Giulio Nannetti, 2017, Journal of pharmaceutical and biomedical analysis.

Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma.

A. Alberti, G. Palù, A. Loregian, 2016, Journal of pharmaceutical and biomedical analysis.

Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication.

G. Palù, A. Loregian, A. Luganini, 2016, Cell chemical biology.

Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections

A. Brancale, M. Heurich, Giulio Nannetti, 2021, Viruses.

Potent and broad‐spectrum cycloheptathiophene‐3‐carboxamide compounds that target the PA‐PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance

G. Palù, A. Loregian, B. Mercorelli, 2019, Antiviral research.

A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells

G. Palù, A. Loregian, B. Mercorelli, 2018, Scientific Reports.

Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin.

G. Palù, A. Loregian, Giulio Nannetti, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Near full-length sequence analysis of HIV type 1 BF recombinants from Italy.

B. Foley, M. Zazzi, Giulio Nannetti, 2012, AIDS Research and Human Retroviruses.

A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.

G. Cruciani, G. Palù, A. Loregian, 2015, Journal of medicinal chemistry.